The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
Open accessAbstract
Breakthrough SARS-CoV-2 infections in fully vaccinated individuals are considered a consequence of waning immunity. Serum antibodies represent the most measurable outcome of vaccine-induced B cell memory. When antibodies decline, memory B cells are expected to persist and perform their function, preventing clinical disease. We investigated whether BNT162b2 mRNA vaccine induces durable and functional B cell memory in vivo against SARS-CoV-2 3, 6, and 9 months after the second dose in a cohort of health care workers (HCWs). While we observed physiological decline of SARS-CoV-2-specific antibodies, memory B cells persist and increase until 9 months after immunization. HCWs with breakthrough infections had no signs of waning immunity. In 3-4 days, memory B cells responded to SARS-CoV-2 infection by producing high levels of specific antibodies in the serum and anti-Spike IgA in the saliva. Antibodies to the viral nucleoprotein were produced with the slow kinetics typical of the response to a novel antigen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“But even recent studies have so far only investigated the second dose and have not evaluated responses to the omicron variant.30 33”
In the citing paper
“By contrast, immunological memory (memory B and T cells) does not wane, and might be important for protection against severe disease.33”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Levin, E. G., Lustig, Y., Cohen, C., Fluss, R., Indenbaum, V., Amit, S., Doolman, R., Asraf, K., Mendelson, E., Ziv, A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114583 · Cited by 1,703
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Bergwerk, M., Gonen, T., Lustig, Y., Amit, S., Lipsitch, M., Cohen, C., Mandelboim, M., Levin, E. G., Rubin, C., Indenbaum, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2109072 · Cited by 1,345
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03324-6 · Cited by 1,343
Humoral Immunity Due to Long-Lived Plasma Cells
Slifka, M. K., Antia, R., Whitmire, J. K., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80541-5 · Cited by 1,249
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Kalkstein, N., Mizrahi, B., Alroy-Preis, S., Ash, N., Milo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114255 · Cited by 1,169
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037
Waning Immunity after the BNT162b2 Vaccine in Israel
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Haas, E. J., Milo, R., Alroy-Preis, S., Ash, N., & Huppert, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114228 · Cited by 1,034
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., et al. (2021) · Science · doi:10.1126/science.abm0829 · Cited by 873
Flagged first, then by citations
2 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–111 of 111
Song, R., Liu, L., Pan, Q., Liu, J., Tan, J.-H., Deng, J., Deng, Q., Lin, Z.-J., Chen, M., Peng, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028246
Mortari, E. P., Pulvirenti, F., Marcellini, V., Terreri, S., Salinas, A. F., Ferrari, S., Napoli, G. D., Guadagnolo, D., Sculco, E., Albano, C., et al. (2022) · medRxiv · doi:10.1101/2022.12.24.22283775
Self-citationFant, P., Laurent, S., Désert, P., Combadière, B., Palazzi, X., Choudhary, S., Gervais, F., Broudic, K., Rossi, R., & Gauthier, B. E. (2025) · Toxicologic Pathology · doi:10.1177/01926233251326089
Tiselius, E., Sundberg, E., Amor, A. R., Andersson, H., Varnaite, R., Kolstad, L., Akaberi, D., Ling, J., Harila‐Saari, A. H., Saghafian‐Hedengren, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1613778
Clarke, K. S. P., Stewart, A. T., Sinclair, E. L., Lewis, R., Labeed, F. H., Dunn‐Walters, D. K., & Hughes, M. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-08724-6
Liu, Y., Shi, Y., Zhan, H., Wang, Y., Yuan, W., Xie, Y., Cheng, L., Guo, X., Li, X., Kang, H., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2544466
Pandémies et antibiorésistance
Sansonetti, P. J. (2025) · médecine/sciences · doi:10.1051/medsci/2025127
Seong, H., Yoon, J. G., Nham, E., Choi, Y. J., Noh, J. Y., Cheong, H. J., Kim, W. J., Kim, E. H., Kim, C., Han, Y.-H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26962504
Aquilani, A., Marinaro, F., Tarantino, G., Caiello, I., Nobili, L., Mortari, E. P., Nicolai, R., Petrone, M. I., Castilletti, C., Magni‐Manzoni, S., et al. (2026) · ACR Open Rheumatology · doi:10.1002/acr2.70157
Self-citationEsser, M. J., Diks, A. M., Oosten, L. E. M., Groenland, R. J., de Mooij, B., Teodósio, C., Driessen, G. J. A., van Dongen, J. J. M., & Berkowska, M. A. (2026) · Vaccines · doi:10.3390/vaccines14040297
Mortari, E. P., Laffranchi, M., Cinicola, B. L., Sugoni, C., Barresi, S., Marcellini, V., Agolini, E., Albano, C., Volpe, G., Scarsella, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.17.719191
Self-citation
Metadata
- Authors
- Terreri, S., Piano Mortari, E., Vinci, M. R., Russo, C., Alteri, C., Albano, C., Colavita, F., Gramigna, G., Agrati, C., Linardos, G., Coltella, L., Colagrossi, L., Deriu, G., Ciofi Degli Atti, M., Rizzo, C., Scarsella, M., Brugaletta, R., Camisa, V., Santoro, A., Roscilli, G., Pavoni, E., Muzi, A., Magnavita, N., Scutari, R., Villani, A., Raponi, M., Locatelli, F., Perno, C. F., Zaffina, S., & Carsetti, R.
- Affiliations
- Bambino Gesù Children's Hospital (IT)
- University of Milan (IT)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Carsetti, Rita
- ORCID
- Terreri, Sara
- Russo, Cristina
- Alteri, Claudia
- Colavita, Francesca
- Agrati, Chiara
- Linardos, Giulia
- Coltella, Luana
- Colagrossi, Luna
- Deriu, Gloria
- Rizzo, Caterina
- Scarsella, Marco
- Brugaletta, Rita
- Camisa, Vincenzo
- Santoro, Annapaola
- Roscilli, Giuseppe
- Muzi, Alessia
- Magnavita, Nicola
- Scutari, Rossana
- Villani, Alberto
- Raponi, Massimiliano
- Locatelli, Franco
- Perno, Carlo Federico
- Zaffina, Salvatore
- Carsetti, Rita
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 30
- Issue
- 3
- Pages
- 400-408.e4
- ISSN
- 1931-3128 (ISSN-L)
- PMC
- PMC8820949
- OpenAlex
- W4220881395
- Cited by
- 117
- References
- 43
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 16 · 2023: 30 · 2022: 38
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell Host & Microbe (publishedVersion, cc-by-nc-nd)
- SSRN Electronic Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministero della Salute
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, BNT162b2 mRNA vaccine, memory B cells, breakthrough infection, waning immunity, saliva antibodies, nucleoprotein antibodies, healthcare workers, vaccine durability
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, BNT162 Vaccine, Antibodies, Viral, Humans, Vaccination, Vaccines, Synthetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
